Danaher Corporation $DHR Shares Acquired by Riverbridge Partners LLC

Riverbridge Partners LLC increased its stake in Danaher Corporation (NYSE:DHR) by 9.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 243,517 shares of the conglomerate’s stock after acquiring an additional 20,113 shares during the period. Danaher makes up about 1.6% of Riverbridge Partners LLC’s holdings, making the stock its 19th largest holding. Riverbridge Partners LLC’s holdings in Danaher were worth $53,951,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Gunderson Capital Management LLC acquired a new position in Danaher during the 3rd quarter worth approximately $765,000. EP Wealth Advisors LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $3,807,000. Frank Rimerman Advisors LLC increased its position in shares of Danaher by 181.9% in the 3rd quarter. Frank Rimerman Advisors LLC now owns 40,855 shares of the conglomerate’s stock valued at $9,051,000 after purchasing an additional 26,363 shares during the last quarter. Birch Hill Investment Advisors LLC raised its holdings in shares of Danaher by 9.6% in the 3rd quarter. Birch Hill Investment Advisors LLC now owns 40,549 shares of the conglomerate’s stock valued at $8,984,000 after purchasing an additional 3,553 shares in the last quarter. Finally, Forbes J M & Co. LLP raised its holdings in shares of Danaher by 141.6% in the 3rd quarter. Forbes J M & Co. LLP now owns 4,276 shares of the conglomerate’s stock valued at $947,000 after purchasing an additional 2,506 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on DHR shares. The Goldman Sachs Group reaffirmed a “buy” rating and set a $275.00 price objective on shares of Danaher in a research report on Thursday, October 22nd. Wells Fargo & Company dropped their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. Guggenheim raised their price target on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Finally, Stifel Nicolaus lifted their price target on Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Danaher Stock Performance

Shares of Danaher stock opened at $236.41 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm’s 50 day moving average is $221.10 and its two-hundred day moving average is $201.55. The firm has a market capitalization of $166.32 billion, a P/E ratio of 38.69, a P/E/G ratio of 2.95 and a beta of 0.76.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter in the previous year, the firm earned $1.89 EPS. The company’s revenue was up 8.3% compared to the same quarter last year. Research analysts forecast that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is currently 26.19%.

Insider Buying and Selling at Danaher

In other Danaher news, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the transaction, the chief accounting officer owned 9,107 shares in the company, valued at $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the transaction, the executive vice president directly owned 22,367 shares in the company, valued at approximately $5,158,277.54. The trade was a 8.58% decrease in their position. The SEC filing for this sale provides additional information. 10.80% of the stock is owned by company insiders.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.